期刊文献+

表皮生长因子对小鼠前列腺细胞雌雄激素受体表达的影响 被引量:2

Effects of epidermal growth factor on cellular expression of estrogen and androgen receptors in mouse prostate
下载PDF
导出
摘要 目的分析外源性表皮生长因子(EGF)对小鼠前列腺细胞雌雄激素受体表达的影响,探讨EGF在前列腺增生发生中的可能作用。方法实验采用雄性昆明小鼠60只,随机分为1μg/dEGF和2μg/dEGF处理组和对照组,每组20只。实验组和对照组动物分别给予不同剂量的EGF和蒸馏水皮下注射,每日1次,连续28d。采用FCM方法定量分析不同剂量EGF处理组和对照小鼠前列腺细胞雌雄激素受体阳性标记率和表达水平。结果经EGF处理后,前列腺细胞雌激素受体阳性标记率和表达强度均明显升高(P<0.01),2μg/dEGF组雌激素受体表达强度明显高于1μg/dEGF处理组(P<0.01);EGF处理后前列腺细胞雄激素受体阳性标记率和表达强度均明显高于对照组(P<0.05),但不同剂量EGF处理对前列腺细胞雄激素受体表达的影响未见明显差异。结论EGF可调控前列腺细胞雌雄激素受体高表达,可能在前列腺增生的发生中发挥一定作用。 Objective To investigate the effects of epidermal growth factor (EGF)on estrogen receptor (ER) and androgen receptor (AR) in mouse prostate cells and explore the putative role of EGF in prostatic hyperplasia. Methods Sixty male Kunming mice were randomly divided into two EGF groups and one control group (n=20) and subjected to subcutaneous injection of 1 and 2μg/day EGF and distilled water, respectively, for 28 consecutive days. The cellular expression of ER and AR in the prostate of mice in different groups was evaluated by flow cytometry. Results Compared with the control group, the positivity rate of ER and its expression level were significantly increased in the mouse prostate after EGF treatment (P〈0.01), and the ER expression level was significantly higher in mouse with 2 μg/day EGF treatment than in those treated with 2 μg/day EGF (P〈0.01). AR positivity rate and expression level also increased significantly in comparison with the control group (P〈0.05), but no significant variation was found between 1 μg/day and 2 μg/day EGF groups. Conclusion EGF can increase the cellular expression of ER and AR in mice prostate and may play a role in the pathogenesis of prostatic hyperplasia.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2006年第10期1473-1475,共3页 Journal of Southern Medical University
关键词 前列腺增生 表皮生长因子 雌雄激素受体 流式细胞术 小鼠 prostatic hyperplasia epidermal growth factors estrogen receptors androgen receptors mice
  • 相关文献

参考文献8

  • 1马腾骧.前列腺增生的病因[A].郭应禄.前列腺增生及前列腺癌[M].北京:人民卫生出版社,1998:40-54.
  • 2Boehm S,Nirnberger G,Ferrari P.Estrogen suppression as a pharmocotherapeutic strategy in the medical treatment of benign prastatic hyperplasia:evidence for its efficacy from studies with mepartricin[J].Wien Klin Wochenschr,1998,110:817-23.
  • 3刘岩,蔡文清,贾彬.雄激素对实验性前列腺增生的影响[J].河北医科大学学报,2003,24(2):79-81. 被引量:7
  • 4Nakhla AM,Kham MS,Romas NP,et al.Estradiol causes the rapid accumulation of camp in human prostate[J].Proc Natl Acad Sci USA,1994,91:5402-5.
  • 5蔡文清,凌亦凌,张勇,王东彬,黎玮,秦同文.老年前列腺增生症各区细胞雌雄激素受体表达的意义[J].中华物理医学与康复杂志,2000,22(2):103-105. 被引量:3
  • 6Smith P,Rhodes NP,Ke Y,et al.Relationship between upregulated oestrogen receptors and expression of growth factors in cultured human prostatic stromal cells exposed to estradiol or dihydrotestosterone[J].Prostate Cancer Prostatic Dis,2004,7(1):57-62.
  • 7Smith P,Rhodes NP,Ke Y,et al.Upregulation of estrogen and androgen receptors modulate expression of FGF-2 and FGF-7 in human,cultured,prostatic stromal cells exposed to high concentrations of estradiol[J].Prostate Cancer Prostatic Dis,2002,5(2):105-10,
  • 8Gregory CW,Fei X,Ponguta LA,et al.Epidermal growth factor increases coactivation of the androgen receptor in recurrent prostate cancer[J].J Biol Chem,2004,279(8):7119-30.

二级参考文献3

  • 1张朝佑,人体解剖学.上(第2版),1998年,544页
  • 2吴阶平,泌尿外科,1993年,938页
  • 3钱伯初.一个新的前列腺增生模型—小鼠尿生殖窦植入法[J].中国药理学通报,1989,5(1):58-59.

共引文献8

同被引文献9

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部